Meda rejects revised offer from Mylan

by The Associated Press

Swedish pharmaceutical company Meda says it has rejected another offer from U.S. generic drugmaker Mylan Inc.

Meda says its board decided to reject a revised Mylan proposal because the deal lacks support from Meda's largest shareholder, which the did not name in a brief statement. It also says the board turned down the offer due to a strong belief in Meda's potential as a stand-alone company.

Meda says all contact between the companies has ended with no further actions. The Swedish company also rebuffed an approach from Mylan earlier this month.

Mylan representatives did not immediately return a call seeking comment.

Meda's products include the eczema treatment Elidel and the antiseptic Betadine. It says its products are sold in more than 120 countries.

Mylan is based in Canonsburg, Pa.

Related Stories

Indian drugs group eyes $5 bn Swedish deal

date May 31, 2013

Indian group Sun Pharmaceutical Industries is in talks to buy leading Swedish drugmaker Meda AB in what could result in a $5 billion takeover, the Wall Street Journal reported on Friday.

US drug firm Mylan to buy Indian firm for $1.6 bn

date Feb 27, 2013

US generic drugs specialist Mylan said Thursday it would buy a unit of India's pharma firm Strides Arcolab for $1.6 billion, boosting its presence in the high-growth injectable drugs market.

US drugs firm Mylan completes $1.75 bln India buyout

date Dec 05, 2013

US generic drug specialist Mylan said Thursday it had completed its $1.75 billion acquisition of a unit of India's Strides Arcolab, boosting its presence in the high-growth injectable drugs market.

Recommended for you

FDA warns of bogus botox

date 9 hours ago

(HealthDay)—Counterfeit Botox may have been distributed to doctors' offices and medical clinics across the United States, the U.S. Food and Drug Administration warns.

Fake malaria drugs not as common as previously reported

date 15 hours ago

A rigorous analysis of antimalarial drug quality conducted in Cambodia and Tanzania found no evidence of fake medicines, according to new research published in the American Journal of Tropical Medicine and Hygiene.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.